WHO offers global perspectives on obesity and weight management strategies
Automated systems and regular calibration of equipment help maintain uniformity
12 mg target dose (TRIUMPH-1, TRIUMPH-2, TRIUMPH-4) 9 mg target dose (TRIUMPH-1, TRIUMPH-2, TRIUMPH-4) 4 mg target dose (TRIUMPH-1, TRIUMPH-2 only) What changed from Phase 2 to Phase 3 The key differences in the Phase 3 titration schedule: 6 mg intermediate step added
Moderate pain lasting more than 3 weeks, or severe pain that limits function, warrants immediate communication with your care providerthese may signal that your dose pace is too aggressive for your individual physiology
risk may be higher with rapid weight loss
The dopamine angle is interesting, though still being studied